Market Overview
According to the MarkNtel Advisors’ research report, “Global Tissue Imaging Market Analysis, 2021”, the market is likely to grow at a CAGR of around 8.96% during 2021-26 due to factors like the increasing identification of the early detection of diseases & diagnosis and growth of chronic disease cases. Alongside that, extensive investments by businesses across the globe in the healthcare sector and advanced technologies like AI & machine learning algorithms due to their efficiency in the early detection of diseases and their treatment are other prominent factors contributing to the market growth.
Impact of COVID-19
The outbreak of the Covid-19 pandemic had the most significant impact on the market and brought extensive challenges, especially in the pharmaceutical industry globally. It is now challenging for industries to return to their optimum pace, especially in developing countries across different regions. Further, the impact of the pandemic reduced overall trade and imports, leading to a significant downfall in the market. However, with the gradual lifting of restrictions by governments, the market growth is likely to regain its pace in the forecast period.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2016-19 |
| Base Year: 2020 | |
| Forecast Period: 2021-26 | |
| CAGR (2021-2026) | 8.96% |
| Regions Covered | North America: USA, Canada |
| Europe: Germany, The UK, France | |
| Asia-Pacific: China, India, Japan, South Korea, Australia and Others | |
| South America: Brazil, Mexico | |
| Middle East & Africa: UAE, Saudi Arabia, South Africa | |
| Key Companies Profiled | Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others. |
| Unit Denominations | USD Million/Billion |
Market Segmentation
Digital Pathology To Fuel The Market Share
Based on technology type, Digital Pathology is likely to fuel market growth in the coming years. The key factors leading to the rise include high-tech contributors with their predominant preference for synergistic activities like collaborations to sustain the enforcement globally and improve dominance. Hence, the global tissue imaging market is likely to witness substantial growth in the forecast years, reveals MarkNtel Advisors in their research report, "Global Tissue Imaging Market Analysis, 2021."
Hospitals & Diagnostic Laboratories To Possess Largest Market Share
Based on End-User Industries, Hospitals & Diagnostic Laboratories are likely to possess the largest market share in the forecast period due to the increasing cases of people with chronic diseases that need tools for tissue imaging and the integration of digital technology in tissue imaging. Moreover, a gradual shift towards better infrastructure of hospitals, operation rooms, and healthcare shall also fuel the Global Tissue Imaging Market growth in the forecast period.
